TD Global Healthcare Leaders ETF (TDOC.TO)
17.23
+0.13 (+0.76%)
CAD |
TSX |
Feb 03, 16:00
Price Chart
Key Stats
Customize
Expense Ratio | Discount or Premium to NAV | Total Assets Under Management | 30-Day Average Daily Volume |
---|---|---|---|
0.38% | 0.32% | 39.51M | 6986.33 |
Dividend Yield | Turnover Ratio | 1 Year Fund Level Flows | Max Drawdown (All) |
1.15% | 31.55% | 15.32M | Upgrade |
Basic Info
Investment Strategy | |
The ETF seeks to track, to the extent reasonably possible and before the deduction of fees and expenses, the performance of a global equity index which measures the investment return of global issuers related to healthcare. Currently, this TD ETF seeks to track the Solactive Global Healthcare Leaders Index (CA NTR) (or any successor thereto). Solactive Global Healthcare Leaders Index (CA NTR) intends to track the performance of securities of global large and mid-capitalization issuers that are related to healthcare while imposing a limit of 2% to any single issuer. Constituents are subject to minimum market capitalization and liquidity screens. |
General | |
Security Type | Exchange-Traded Fund |
Equity Style | Large Cap/Blend |
Fixed Income Style | -- |
Broad Asset Class | -- |
Broad Category | Equity |
Category Name | Sector Equity |
Category Index | Morningstar Gbl GR CAD |
Global Category Name | Healthcare Sector Equity |
YCharts Categorization | Healthcare Equity |
YCharts Benchmark | S&P 1500 Health Care (Sector) Total Return (^SP15HCSTR) |
Prospectus Objective | -- |
Fund Owner Firm Name | TD Asset Management Inc |
Prospectus Benchmark Index | |
Solactive Glb Healthcare Leaders NR CAD | 100.0% |
Broad Asset Class Benchmark Index | |
^SPTSX60TR | 100.0% |
Manager Tenure | |
Not Disclosed | 1.82 yrs |
Net Fund Flows Versus Category
1 Month
% Rank:
--
--
Category Low
--
Category High
1 Year
% Rank:
19
15.32M
-112.96M
Category Low
467.85M
Category High
3 Months
% Rank:
--
--
Category Low
--
Category High
3 Years
% Rank:
--
--
Category Low
--
Category High
6 Months
% Rank:
--
--
Category Low
--
Category High
5 Years
% Rank:
--
--
Category Low
--
Category High
YTD
% Rank:
--
--
Category Low
--
Category High
10 Years
% Rank:
--
--
Category Low
--
Category High
As of January 31, 2023
Performance Versus Category
As of February 03, 2023. Returns for periods of 1 year and above are annualized.
Annual Total Returns Versus Peers
As of February 03, 2023.
Asset Allocation
Top 10 Holdings
Name | % Weight | Price | % Change |
---|---|---|---|
Gilead Sciences Inc | 2.42% | 84.50 | 3.82% |
Novo Nordisk A/S Class B
|
2.36% | -- | -- |
Merck & Co Inc | 2.31% | 102.94 | -0.50% |
Sanofi SA
|
2.23% | -- | -- |
AstraZeneca PLC
|
2.22% | -- | -- |
Intuitive Surgical Inc | 2.18% | 254.68 | -2.38% |
Novartis AG
|
2.16% | -- | -- |
Pfizer Inc | 2.14% | 44.06 | -0.63% |
AbbVie Inc | 2.08% | 145.20 | 0.25% |
Cigna Corp | 2.08% | 292.59 | -2.96% |
News
Headline
Wire
Time (ET)
PR Newswire
12/21 12:50
Yahoo
11/16 07:05
PR Newswire
04/05 08:00
Basic Info
Investment Strategy | |
The ETF seeks to track, to the extent reasonably possible and before the deduction of fees and expenses, the performance of a global equity index which measures the investment return of global issuers related to healthcare. Currently, this TD ETF seeks to track the Solactive Global Healthcare Leaders Index (CA NTR) (or any successor thereto). Solactive Global Healthcare Leaders Index (CA NTR) intends to track the performance of securities of global large and mid-capitalization issuers that are related to healthcare while imposing a limit of 2% to any single issuer. Constituents are subject to minimum market capitalization and liquidity screens. |
General | |
Security Type | Exchange-Traded Fund |
Equity Style | Large Cap/Blend |
Fixed Income Style | -- |
Broad Asset Class | -- |
Broad Category | Equity |
Category Name | Sector Equity |
Category Index | Morningstar Gbl GR CAD |
Global Category Name | Healthcare Sector Equity |
YCharts Categorization | Healthcare Equity |
YCharts Benchmark | S&P 1500 Health Care (Sector) Total Return (^SP15HCSTR) |
Prospectus Objective | -- |
Fund Owner Firm Name | TD Asset Management Inc |
Prospectus Benchmark Index | |
Solactive Glb Healthcare Leaders NR CAD | 100.0% |
Broad Asset Class Benchmark Index | |
^SPTSX60TR | 100.0% |
Manager Tenure | |
Not Disclosed | 1.82 yrs |
Fundamentals
General | |
Distribution Yield | Upgrade |
Dividend Yield TTM (2-3-23) | 1.15% |
30-Day SEC Yield | -- |
7-Day SEC Yield | -- |
Number of Holdings | Upgrade |
Stock | |
Weighted Average PE Ratio | 22.24 |
Weighted Average Price to Sales Ratio | Upgrade |
Weighted Average Price to Book Ratio | Upgrade |
Weighted Median ROE | Upgrade |
Weighted Median ROA | Upgrade |
Forecasted Dividend Yield | Upgrade |
Forecasted PE Ratio | Upgrade |
Forecasted Price to Sales Ratio | Upgrade |
Forecasted Price to Book Ratio | Upgrade |
As of December 31, 2022
Growth Estimates
Fund Details
Key Dates | |
Inception Date | 4/7/2021 |
Last Annual Report Date | 12/31/2021 |
Last Prospectus Date | 2/24/2022 |
Attributes | |
Index Fund |
|
Inverse Fund | No |
Leveraged Fund | No |
Fund of Funds | No |
Currency Hedged Fund | No |
Synthetic Replication Fund | No |
Has Dividend Investment Plan | No |
Socially Responsible Fund | No |
News
Headline
Wire
Time (ET)
PR Newswire
12/21 12:50
Yahoo
11/16 07:05
PR Newswire
04/05 08:00